Cargando…
Genome-Wide DNA Changes Acquired by Candida albicans Caspofungin-Adapted Mutants
Drugs from the echinocandin (ECN) class are now recommended ‘front-line’ treatments of infections caused by a prevailing fungal pathogen, C. albicans. However, the increased use of ECNs is associated with a rising resistance to ECNs. As the acquisition of ECN resistance in C. albicans is viewed as a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458384/ https://www.ncbi.nlm.nih.gov/pubmed/37630430 http://dx.doi.org/10.3390/microorganisms11081870 |